{"url_path":"/sec/crmd/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1410098/0001410098-26-000021-index.html","accession_number":"0001410098-26-000021","cik":"0001410098","ticker":"CRMD","issuer_name":"CorMedix Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1410098/0001410098-26-000021-index.html","primary_entity_key":"0001410098","primary_entity_name":"CorMedix Inc."},"word_count":536,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\nOn May 12, 2026, the Company entered into an amended and restated executive employment agreement (the “A&R Employment Agreements”) with each of (i) Susan Blum, the Company’s Executive Vice President and Chief Financial Officer, (ii) Elizabeth Hurlburt, the Company’s Executive Vice President and Chief Operating Officer, and (iii) Beth Zelnick Kaufman, the Company’s Executive Vice President, Chief Legal and Compliance Officer, and Corporate Secretary (each, an “Officer”).\n\nThe A&R Employment Agreements provide that Mses. Blum, Hurlburt, and Zelnick Kaufman continue to receive their current annual base salaries of $503,000, $528,000, and $512,000, respectively. Each of the Officer’s target annual bonus opportunity remains at 45% of her base salary, with the actual amount of any annual bonus to be determined based on achievement of Company and individual objectives set by the Board (or its compensation committee). Each Officer will also remain eligible to receive grants pursuant to the Company’s 2019 Omnibus Stock Incentive Plan or any successor thereto (the “Equity Plan”) from time to time as determined by the Board (or its compensation committee).\n\nUpon a termination of the Officer’s employment by the Company other than for Cause (as defined in the A&R Employment Agreements) (other than as a result of death or disability) or by the Officer for Good Reason (as defined in the A&R Employment Agreements), and subject to the Officer’s execution and non-revocation of a customary release of claims, the Officer will be entitled to the following severance benefits: (i) continuation of base salary for 12 months (or, if such termination occurs within 24 months following a Corporate Transaction (as defined in the Equity Plan), 125% of the sum of such Officer’s base salary and target annual bonus, paid over 15 months), (ii) payment of a prorated annual bonus for the year of termination based on the actual achievement of the specified bonus objectives, (iii) subsidized COBRA premiums for up to 12 (or, if such termination occurs within 24 months following a Corporate Transaction, 15) months, (iv) acceleration of unvested equity awards scheduled to vest on or before the next succeeding anniversary of the date of the Officer’s termination, provided that performance-based awards will not accelerate unless and until their performance conditions are satisfied (or, if such termination occurs within 24 months following a Corporate Transaction, full acceleration of all unvested equity awards), and (v) any then-unpaid annual bonus in respect of service during the year preceding the year of termination.\n\nThe A&R Employment Agreements also contain customary confidentiality and non-disparagement covenants and non-competition and non-solicitation of employees and customers covenants that apply during employment and for a period of 12 months following any termination of employment.\n\nThe foregoing description of the A&R Employment Agreements is qualified in its entirety by reference to the full text of the A&R Employment Agreements, copies of which are filed as Exhibits 10.1, 10.2 and 10.3 to this Quarterly Report on Form 10-Q and are incorporated by reference herein.\n\nNone of our officers or directors, as defined in Rule 16a-1(f), adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the three months ended March 31, 2026.\n\n32\n\n[Table of](#i0fdbfbedd57d460da77b9a8ab76925e1_7)[Contents](#i0fdbfbedd57d460da77b9a8ab76925e1_7)"}